Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KEAP1 | Q14145 | 1/20 | 0.56 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.56 |
| ▸ | GLA | P06280 | 1/20 | 0.53 |
| ▸ | GAA | P10253 | 1/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.52 |
| ▸ | HPGD | P15428 | 3/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
| ▸ | MEN1 | O00255 | 3/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.52 |
| ▸ | PARP1 | P09874 | 1/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 4/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.47 |
| ▸ | FEN1 | P39748 | 1/20 | 0.47 |
| ▸ | XDH | P47989 | 2/20 | 0.46 |
| ▸ | GHSR | Q92847 | 1/20 | 0.46 |
| ▸ | NGFR | P08138 | 1/20 | 0.46 |
| ▸ | PKM | P14618 | 1/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19211167 | 0.84 | KDM4E (0.57) | GLAGAAKDM4EALDH1A1HPGD | |
| SCHEMBL17205044 | 0.82 | HPGD (0.56) | GLAGAAKDM4EALDH1A1HPGD | |
| SCHEMBL11617401 | 0.82 | ALDH1A1 (0.52) | GLAGAAKDM4EALDH1A1HPGD | |
| SCHEMBL1503904 | 0.82 | HPGD (0.56) | GLAGAAKDM4EALDH1A1HPGD | |
| SCHEMBL1210328 | 0.82 | ALDH1A1 (0.52) | GLAGAAKDM4EALDH1A1HPGD | |
| SCHEMBL13234526 | 0.82 | ALDH1A1 (0.61) | GLAGAAKDM4EALDH1A1HPGD | |
| SCHEMBL9452207 | 0.82 | KDM4E (0.57) | GLAGAAKDM4EALDH1A1HPGD | |
| SCHEMBL9452271 | 0.81 | NGFR (0.67) | KEAP1NFE2L2GLAGAAKDM4E | |
| SCHEMBL57291 | 0.80 | KDM4E (0.66) | GLAGAAKDM4EALDH1A1HPGD | |
| SCHEMBL31243255 | 0.80 | KDM4E (0.66) | GLAGAAKDM4EALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7470708-B2 | Acidic quinoline derivatives and their use for the prevention and/or treatment of hyperglycaemia-related pathologies | MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) | 2008-12-30 | — | — | US | disclosed |
| EP-1933811-A2 | BANDED CONTROLLED RELEASE NANOPARTICLE ACTIVE AGENT FORMULATION DOSAGE FORMS AND METHODS | Alza Corporation (US) | 2008-06-25 | — | — | EP | disclosed |
| EP-1696924-B1 | ACIDIC QUINOLINE DERIVATIVES AND THEIR USE FOR THE PREVENTION AND/OR TREATMENT OF HYPERGLYCAEMIA-RELATED PATHOLOGIES | MERCK PATENT GMBH (DE) | 2008-03-26 | — | — | EP | disclosed |
| EP-1898885-A1 | METHODS AND DOSAGE FORMS FOR REDUCING SIDE EFFECTS OF CARBAMATE COMPOUNDS | Alza Corporation (US) | 2008-03-19 | — | — | EP | disclosed |
| WO-2008002567-A2 | METHODS OF TREATING CONDITIONS BY SUSTAINED RELEASE ADMINISTRATION OF BENZIMIDAZOLE DERIVATIVES | ALZA CORPORATION (US) | 2008-01-03 | — | — | WO | disclosed |
| EP-1791520-A2 | CONTROLLED RELEASE NANOPARTICLE ACTIVE AGENT FORMULATION DOSAGE FORMS AND METHODS | Alza Corporation (US) | 2007-06-06 | — | — | EP | disclosed |
| WO-2007041079-A2 | BANDED CONTROLLED RELEASE NANOPARTICLE ACTIVE AGENT FORMULATION DOSAGE FORMS AND METHODS | ALZA CORPORATION (US) | 2007-04-12 | — | — | WO | disclosed |
| WO-2007016388-A2 | LIQUID FORMULATIONS FOR CONTROLLED DELIVERY OF BENZISOXAZOLE DERIVATIVES | ALZA CORPORATION (US) | 2007-02-08 | — | — | WO | disclosed |
| WO-2007002906-A1 | METHODS AND DOSAGE FORMS FOR REDUCING SIDE EFFECTS OF CARBAMATE COMPOUNDS | ALZA CORPORATION (US) | 2007-01-04 | — | — | WO | disclosed |
| EP-1696924-A1 | ACIDIC QUINOLINE DERIVATIVES AND THEIR USE FOR THE PREVENTION AND/OR TREATMENT OF HYPERGLYCAEMIA-RELATED PATHOLOGIES | MERCK PATENT GmbH (DE) | 2006-09-06 | — | — | EP | disclosed |
| WO-2006085856-A1 | METHODS AND DOSAGE FORMS FOR REDUCING SIDE EFFECTS OF BENZISOZAZOLE DERIVATIVES | ALZA CORPORATION (US) | 2006-08-17 | — | — | WO | disclosed |
| WO-2006069133-A2 | IONIC DRUG-DETERGENT COMPLEXES | ALZA CORPORATION (US) | 2006-06-29 | — | — | WO | disclosed |
| WO-2006023286-A2 | CONTROLLED RELEASE NANOPARTICLE ACTIVE AGENT FORMULATION DOSAGE FORMS AND METHODS | ALZA CORPORATION (US) | 2006-03-02 | — | — | WO | disclosed |
| WO-2005063244-A1 | ACIDIC QUINOLINE DERIVATIVES AND THEIR USE FOR THE PREVENTION AND/OR TREATMENT OF HYPERGLYCAEMIA-RELATED PATHOLOGIES | MERCK PATENT GMBH (DE) | 2005-07-14 | — | — | WO | disclosed |
| EP-1140012-A2 | CONVERSION OF LIQUID FILLED GELATIN CAPSULES INTO CONTROLLED RELEASE SYSTEMS BY MULTIPLE COATINGS | Alza Corporation (US) | 2001-10-10 | — | — | EP | disclosed |
| WO-2000038650-A1 | GASTRIC RETENTION DOSAGE FORM HAVING MULTIPLE LAYERS | ALZA CORPORATION (US) | 2000-07-06 | — | — | WO | disclosed |
| WO-2000035419-A2 | CONVERSION OF LIQUID FILLED GELATIN CAPSULES INTO CONTROLLED RELEASE SYSTEMS BY MULTIPLE COATINGS | ALZA CORPORATION (US) | 2000-06-22 | — | — | WO | disclosed |